Qingdao Baheal Medical INC. (SHE:301015)
China
· Delayed Price · Currency is CNY 21.52
-0.63 (-2.84%)
Mar 9, 2026, 3:04 PM CST
SHE:301015 Market Cap
SHE:301015 has a market cap or net worth of 11.31 billion as of March 9, 2026. Its market cap has decreased by -9.69% in one year.
Market Cap
11.31B
Enterprise Value
12.74B
Revenue
7.58B
Ranking
n/a
PE Ratio
22.20
Stock Price
21.52
Market Cap Chart
Since June 30, 2021, SHE:301015's market cap has decreased from 29.49B to 11.31B, a decrease of -61.64%. That is a compound annual growth rate of -18.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.64B | -6.14% |
| Dec 31, 2025 | 12.40B | -2.52% |
| Dec 31, 2024 | 12.73B | -32.42% |
| Dec 29, 2023 | 18.83B | 50.42% |
| Dec 30, 2022 | 12.52B | -21.32% |
| Dec 31, 2021 | 15.91B | -46.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China National Accord Medicines Corporation | 13.26B |
| C.Q. Pharmaceutical Holding | 10.01B |
| China Meheco Group | 15.69B |
| Liaoning Cheng Da | 18.45B |
| Guangxi LiuYao Group | 6.82B |
| China National Medicines Corporation | 22.64B |
| Jointown Pharmaceutical Group | 26.23B |
| Realcan Pharmaceutical Group | 4.78B |